- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06295601
Telerehabilitation Based Motor Imagery and Action Observation Training in Multiple Sclerosis
May 30, 2026 updated by: Burcu Talu, Inonu University
Effect of Telerehabilitation-Based Motor Imagery and Action Observation Training on Balance and Functional Mobility in Multiple Sclerosis: Randomized Controlled Study
This study aims to investigate the effects of the treatment combination consisting of motor imagery and action observation therapy on balance, functional mobility, lower extremity muscle strength, fatigue and quality of life.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study population was participants with relapsing remitting multiple sclerosis.
The traditional rehabilitation program consists of a joint treatment in which lower extremity strengthening and balance exercises are carried out synchronously for the experimental and control groups.
Motor imagery and action observation therapy based on telerehabilitation of certain movements will be applied to the experimental group.
All treatments will be carried out online via the Whatsapp program.
The treatment program will be applied 3 times a week for 6 weeks.
Evaluations will be made before and after the treatment program.
Assessments include balance, lower extremity muscle strength and functional mobility, fatigue, and quality of life.
Study Type
Interventional
Enrollment (Actual)
29
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Battalgazi
-
Malatya, Battalgazi, Turkey (Türkiye), 44280
- Inonu University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Being diagnosed with mulltiple sclerosis according to the McDonald criteria
- Expanded Disability Status Scale<5.5,
- Being between the ages of 18-65,
- Mini mental test score>24,
- Have a phone that can adapt to participating in a video call
Exclusion Criteria:
- Having another additional neurological disease that may cause balance and coordination disorders,
- having received physical therapy and regularly engaged in sports in the last 6 months
- Having an attack in the last 3 months
- Refusal to participate in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental group
Individuals will receive standard rehabilitation and telerehabilitation-based motor imagery and action observation therapy.
|
The program consists of a joint treatment in which lower extremity strengthening and balance exercises are carried out synchronously.
The program will include a total of 5 minutes of warm-up, 5 minutes of cool-down and 30 minutes of exercises related to the program.
The difficulty of the program will increase by changing the number of exercises and increasing the weight in strengthening exercises.
Progress in balance and coordination exercises will vary by changing the ground, increasing the standing time, and keeping the eyes open and closed.
In the experimental group, in addition to traditional telerehabilitation, action observation and motor imagery of 4 exercises will be performed in each session.
A video will be prepared for 4 exercises.
Then, the participant will perform 2 minutes of action observation of each movement, followed by 1 minute of motor imagery.
In addition to the traditional telerehabilitation program, a 12-minute combination of action observation and motor imagery will be performed in each session.
Exercises will be changed every two weeks, gradually increasing the difficulty.
|
|
Experimental: Control group
Individuals will receive standard rehabilitation.
|
The program consists of a joint treatment in which lower extremity strengthening and balance exercises are carried out synchronously.
The program will include a total of 5 minutes of warm-up, 5 minutes of cool-down and 30 minutes of exercises related to the program.
The difficulty of the program will increase by changing the number of exercises and increasing the weight in strengthening exercises.
Progress in balance and coordination exercises will vary by changing the ground, increasing the standing time, and keeping the eyes open and closed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Berg Balance Scale
Time Frame: Baseline
|
Berg Balance Scale consists of a total of 14 items.
Evaluation for each stage is made between 0-4.
Higher score indicates better functional balance performance
|
Baseline
|
|
Berg Balance Scale
Time Frame: 6 weeks after baseline
|
Berg Balance Scale consists of a total of 14 items.
Evaluation for each stage is made between 0-4.
Higher score indicates better functional balance performance
|
6 weeks after baseline
|
|
Muscle strength and functional mobility
Time Frame: Baseline
|
The participant will be asked to sit and stand up from a standard chair between 42-45 cm, with hands crossed on the chest, without support, 5 times.
The time will be stopped when the participant completes the last sitting.
It will be recorded in seconds.
|
Baseline
|
|
Muscle strength and functional mobility
Time Frame: 6 weeks after baseline
|
The participant will be asked to sit and stand up from a standard chair between 42-45 cm, with hands crossed on the chest, without support, 5 times.
The time will be stopped when the participant completes the last sitting.
It will be recorded in seconds.
|
6 weeks after baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fatigue Severity Scale
Time Frame: Baseline
|
This scale consists of a total of 9 items and is scored between 0-7.
>4 points indicate fatigue
|
Baseline
|
|
Fatigue Severity Scale
Time Frame: 6 weeks after baseline
|
This scale consists of a total of 9 items and is scored between 0-7.
>4 points indicate fatigue
|
6 weeks after baseline
|
|
Multiple Sclerosis International Quality of Life (MusiQoL) questionnaire
Time Frame: Baseline
|
The scale consists of 31 questions in 9 dimensions (subscales).
The index score is calculated as the average of these subscale scores.
All 9 dimensions and the index score are linearly transformed and standardized on a scale from 0 to 100; where 0 indicates the worst possible level of quality of life and 100 indicates the best level.
|
Baseline
|
|
Multiple Sclerosis International Quality of Life (MusiQoL) questionnaire
Time Frame: 6 weeks after baseline
|
The scale consists of 31 questions in 9 dimensions (subscales).
The index score is calculated as the average of these subscale scores.
All 9 dimensions and the index score are linearly transformed and standardized on a scale from 0 to 100; where 0 indicates the worst possible level of quality of life and 100 indicates the best level.
|
6 weeks after baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Burcu talu, Inonu University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 20, 2025
Primary Completion (Actual)
November 15, 2025
Study Completion (Actual)
November 25, 2025
Study Registration Dates
First Submitted
February 21, 2024
First Submitted That Met QC Criteria
March 4, 2024
First Posted (Actual)
March 6, 2024
Study Record Updates
Last Update Posted (Actual)
June 2, 2026
Last Update Submitted That Met QC Criteria
May 30, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2025/7369
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Study data can be shared with other researchers if desired.
IPD Sharing Time Frame
After the study was published
IPD Sharing Access Criteria
If requested from the authors, it can be shared with researchers at the authors' discretion.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on Traditional rehabilitation
-
Hasan Kalyoncu UniversityCompletedMultiple Sclerosis | Muscle Spasticity | Cervical Region Disorder Nos | Pressure AreaTurkey
-
Fondazione Don Carlo Gnocchi OnlusIstituti Clinici Scientifici Maugeri SpA; IRCCS National Neurological Institute... and other collaboratorsRecruiting
-
Assistance Publique - Hôpitaux de ParisCompletedPost-stroke Hemiparetic Patients (at Least 6 Months Post Stroke) | Age Between 18-75 YearsFrance
-
University of BeykentCompletedPhysiotherapy | Chronic Stroke | Dual TaskTurkey
-
Nanjing First Hospital, Nanjing Medical UniversityCompletedDistal Radius FractureChina
-
Assiut UniversityNot yet recruitingStroke | Ischemic Stroke | Hemorrhagic Stroke
-
Fondazione Don Carlo Gnocchi OnlusIstituto Italiano di Tecnologia; Ospedale Policlinico San MartinoRecruiting
-
Centre Hospitalier Universitaire, AmiensUniversity Hospital, Lille; Centre Hospitalier Arras; CH Le Havre; CH Compiègne; CENTRE... and other collaboratorsRecruiting
-
Manchester University NHS Foundation TrustActive, not recruitingRotator Cuff Tear | Rotator Cuff Tear or Rupture, Not Specified as TraumaticUnited Kingdom
-
Peking University Third HospitalRecruiting